Literature DB >> 21982519

Treatment intensity at end of life--time to act on the evidence.

Amy S Kelley1.   

Abstract

Mesh：

Year:  2011        PMID： 21982519     DOI： 10.1016/S0140-6736(11)61420-7

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  7 in total

1.  Racial variation in the use of life-sustaining treatments among patients who die after major elective surgery.

Authors:  Roland A Hernandez; Nathanael D Hevelone; Lenny Lopez; Samuel R G Finlayson; Eva Chittenden; Zara Cooper
Journal:  Am J Surg       Date:  2014-10-13       Impact factor: 2.565

2.  "Well, I think there is great variation...": a qualitative study of oncologists' experiences and views regarding medical criteria and other factors relevant to treatment decisions in advanced cancer.

Authors:  Jan Schildmann; Jacinta Tan; Sabine Salloch; Jochen Vollmann
Journal:  Oncologist       Date:  2013-01-03

3.  The Impact of Reported Hospice Preferred Practices on Hospital Utilization at the End of Life.

Authors:  Melissa D Aldridge; Andrew J Epstein; Abraham A Brody; Eric J Lee; Emily Cherlin; Elizabeth H Bradley
Journal:  Med Care       Date:  2016-07       Impact factor: 2.983

4.  The Cost of Uncertain Life Span.

Authors:  Ryan D Edwards
Journal:  J Popul Econ       Date:  2008-06-01

Review 5.  Measuring intensity of end of life care: a systematic review.

Authors:  Xhyljeta Luta; Maud Maessen; Matthias Egger; Andreas E Stuck; David Goodman; Kerri M Clough-Gorr
Journal:  PLoS One       Date:  2015-04-14       Impact factor: 3.240

6.  Limiting treatment and shortening of life: data from a cross-sectional survey in Germany on frequencies, determinants and patients' involvement.

Authors:  Birte Malena Dahmen; Jochen Vollmann; Stephan Nadolny; Jan Schildmann
Journal:  BMC Palliat Care       Date:  2017-01-17       Impact factor: 3.234

7.  Association of sleep duration with risk of all-cause mortality and poor quality of dying in oldest-old people: a community-based longitudinal study.

Authors:  Chengbei Hou; Yinan Lin; Zachary Zimmer; Lap Ah Tse; Xianghua Fang
Journal:  BMC Geriatr       Date:  2020-09-21       Impact factor: 3.921
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.